Table 2.
Odds Ratio | 95% Confidence Interval | |
---|---|---|
Years in practice | ||
1-9 years | Ref | |
10-19 years | 0.68 | 0.13-3.48 |
20-29 years | 0.74 | 0.17-3.30 |
≥30 years | 0.88 | 0.17-4.49 |
Number of patients seen/typical week | ||
≤75 patients | Ref | |
76-100 patients | 1.66 | 0.55-5.02 |
>100 patients | 0.97 | 0.30-3.20 |
Clinical guidelines read | ||
None | Ref | |
ATA or NCCN or both | 2.30 | 0.66-7.96 |
Guidelines are the most influential source in treating thyroid cancer | ||
No | Ref | |
Yes | 4.29 | 1.56-11.82 |
Colleagues are the most influential source in treating thyroid cancer | ||
No | Ref | |
Yes | 1.24 | 0.49-3.17 |
Practice setting | ||
Large medical center | Ref | |
Private practice | 0.82 | 0.29-2.34 |
PCP have the skills necessary to initiate appropriate screening to detect recurrent thyroid cancer | ||
No | Ref | |
Yes | 4.21 | 1.58-11.21 |
PCPs should have responsibility for providing continuing care after treatment | ||
No | Ref | |
Yes | 0.54 | 0.18-1.58 |
*ATA = 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
*NCCN = National Comprehensive Cancer Network’s 2017 “Thyroid Carcinoma: Clinical Practice Guidelines in Oncology”